With a market cap of has a large market cap size. Amgen Inc. (NASDAQ: AMGN) has been on the stock market since its IPO date on the 9/7/1984. Amgen Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Amgen Inc., is 2882.8, and so far today it has a volume of 1867500. Performance year to date since the 9/7/1984 is 6.85%.
To help you determine whether Amgen Inc. is undervalued the following values will help you decide. P/E is 17.41 and forward P/E is 13.63. PEG perhaps more useful shows that Amgen Inc. has a value for PEG of 2.05. P/S ratio is 5.69 and the P/B ratio is 4.24. The P/Cash and P/Free cash flow is 3.65 and 21.34 respectively.
At the current price Amgen Inc. is trading at, 170.13 (0.04% today), Amgen Inc. has a dividend yield of 2.35%, and this is covered by a payout ratio of 36.30%. Earnings per share (EPS) is 9.77, and this is looking to grow in the next year to 9.84% after growing 35.20% this past year. EPS growth quarter over quarter is 14.90%, and 5.90% for sales growth quarter over quarter.
The number of shares outstanding is 751, and the number of shares float is 747.47. The senior management bring insider ownership to 0.20%, and institutional ownership is at 81.20%. The float short is 1.08%, with the short ratio at a value of 2.81. Management has seen a return on assets of 10.10%, and also a return on investment of 12.50%.
The ability for Amgen Inc., to deal with debt, means it current ratio is 4, and quick ratio is 3.7. Long term debt/equity is 0.93 and total debt/equity is 1.1. In terms of margins, Amgen Inc. has a gross margin of 81.40%, with its operating margin at 40.70%, and Amgen Inc. has a profit margin of 33.10%.
The 52 week high is -3.69%, with 34.00% being its 52 week low. The 20 day simple moving average is 3.24% and the 200 day simple moving average is 9.66%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.